New Study Raises More Questions About J&J COVID Vaccine

Video Credit: CBS 2 New York
Published on July 21, 2021 - Duration: 02:01s

New Study Raises More Questions About J&J COVID Vaccine

The Delta variant is now responsible for 83% of new COVID cases in the U.S. Now, a preliminary study not yet peer reviewed suggests the Johnson & Johnson vaccine may not be as effective against the variant as Modern and Pfizer.

CBS2's Dr. Max Gomez explains.


You are here

Related videos from verified sources

New CDC assessment of delta variant 02:50
Video credit: ABC 10 News | San Diego - Published on July 31, 2021 

NYC Mayor Offers $100 Incentive for Vaccinations at City-Run Sites 01:31
Video credit: Wibbitz Top Stories - Published on July 30, 2021 

Water Vapor Is Discovered for First Time on Jupiter's Moon, Ganymede 01:30
Video credit: Wibbitz Top Stories - Published on July 30, 2021 

You might like